As of November 30, 2023 T3 Labs is Part of Veranex. Click Here to learn more.
GCMI Design & Development has moved to gcmiatl.org
In October 2018, GCMI and Rambam Medical Center announced the formation of a partnership to help Israeli medtech innovators commercialize their products in the U.S. healthcare market. Earlier this year, Georgia Bio and the Atlanta Chamber of Commerce recognized our work with a 2019 Phoenix Award recognizing leaders who have forged academic and industry relationships…
Yet another edition of the SEMDA Medtech Conference has come and gone. The 2019 edition saw colleagues from 26 states attend and significant diversity among the PitchRounds companies who hailed from AL, AR, GA, FL, KY, MS, NC, SC, TN, TX and VA. Every year, SEMDA is the place to connect with the entirety of…
GCMI would like to extend our congratulations to Ethos Medical for winning first place in the final round of Georgia Tech’s 11th annual InVenture Prize competition. Ethos Medical (previously Neuraline) aims to improve patient outcomes for procedures like spinal taps and epidurals with their ultrasound-based needle guidance system that alerts the anesthesiologist when the needle…
Last August a multi-disciplinary team contributed to Georgia’s first surgery to place 3D-printed tracheal splints in a pediatric patient. The patient who received the groundbreaking surgery is a 7-month-old boy battling both congenital heart disease and tracheo-bronchomalacia, a condition that causes severe life-threatening airway obstruction. During his six-month inpatient stay in the Pediatric Intensive Care…
The American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting is the world’s largest orthopedic conference with over 30,000 attendees annually that include physicians and industry representatives. As a leading preclinical CRO for orthopedic professionals, T3 Labs Orthopedic Program Director, Evan Goldberg attended the 2019 AAOS Meeting earlier this month to keep touch with the pulse…
Our take on the SEMDA 2019 Medtech Conference sponsorship value proposition. GCMI’s mission is to accelerate the pathway to commercialization of innovative medical products. To accomplish this, we need to meet the innovators, the large strategics, investors and consultant partners who all need to work in concert to improve lives and reduce overall healthcare spending.…
Revolutionizing the provision of patient care, improving outcomes and reducing overall cost through new medical technologies is serious business. It takes vision, technical prowess and efficient use of scarce resources in a rigorous regulatory landscape. Last month, The New York Times included the work GCMI and the American Cancer Society are doing with Dr. Darren…
Last year, Ares Health Systems became the first digital health company to enter GCMI’s accelerator, accessing our digital health commercial development expertise and health system relationships to further validate the value of Ares’ MPower care management platform and commence market penetration. “Our confidence in our value proposition has increased since we’ve last talked,” says Ares…
The American Academy of Orthopaedic Surgeons’ Annual Meeting (AAOS) is the premier ortho event of the year: hosting thousands of thought leaders, physicians, scientists and academics seeking the latest in injury prevention and disease treatment of the musculoskeletal system. AAOS 2019 will once again bring the top names in orthopedics together in Las Vegas March…
It might not be the deal monster JPMorgan has become, but one could argue HIMSS is as important, and as noisy, as any other event in healthcare. Our intrepid colleagues Martin Entwistle, president and CEO of Ares Health Systems and Andrew Stevenson, executive director for GCMI braved HIMSS 2019. Their focus: demonstrating the market attractiveness…